SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-288496
Filing Date
2020-11-09
Accepted
2020-11-09 07:37:02
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d99335d8k.htm   iXBRL 8-K 25658
2 EX-99.1 d99335dex991.htm EX-99.1 105304
6 GRAPHIC g99335g1109064309000.jpg GRAPHIC 6244
  Complete submission text file 0001193125-20-288496.txt   277425

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20201109.xsd EX-101.SCH 3090
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20201109_lab.xml EX-101.LAB 18070
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20201109_pre.xml EX-101.PRE 11398
7 EXTRACTED XBRL INSTANCE DOCUMENT d99335d8k_htm.xml XML 3332
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 201296117
SIC: 2834 Pharmaceutical Preparations